Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Search content at Experts@Minnesota
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Honokiol: A novel natural agent for cancer prevention and therapy
S. Arora
, S. Singh
, G. A. Piazza
, C. M. Contreras
, J. Panyam
, A. P. Singh
Pharmaceutics
Research output
:
Contribution to journal
›
Review article
›
peer-review
219
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Honokiol: A novel natural agent for cancer prevention and therapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cancer Prevention
100%
Cancer Therapy
100%
Natural Agents
100%
Honokiol
100%
Clinical Trials
28%
Malignancy
14%
Mammalian Target of Rapamycin (mTOR)
14%
Molecular Targets
14%
Clinical Model
14%
Cancer Progression
14%
Intravenous Administration
14%
Bioactive Natural Products
14%
Pharmacokinetic Profile
14%
Nuclear factor-κB
14%
Cancer Initiation
14%
Antiangiogenic
14%
Anticancer Activity
14%
Antioxidant Properties
14%
Multiple Signaling Pathways
14%
Signal Transducer
14%
4-diol
14%
Human Applications
14%
Anticancer Properties
14%
Biphenyl-2
14%
Magnolia
14%
Epidermal Growth Factor Receptor Inhibitors (EGFRI)
14%
Activator of Transcription 3
14%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Honokiol
100%
Clinical Trial
28%
Molecular Target
14%
Antiangiogenic
14%
Anti-Inflammatory Drug
14%
Natural Product
14%
Propenyl
14%
Immunoglobulin Enhancer Binding Protein
14%
STAT3 Protein
14%
Biphenyl
14%
Bioavailability
14%
Antioxidant
14%
Epidermal Growth Factor Receptor
14%
Mammalian Target of Rapamycin
14%
Pharmacokinetics
14%
Magnolia
14%